Researchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...

Veru's pivot with enobosarm: groundbreaking Phase 2b results enhance GLP-1 therapy outcomes. A positive launch could yield ...

Dozens of Ozempic, Mounjaro and Wegovy users are reporting drug-induced hepatitis, prompting medical experts to call for ...

As of 2021–2022, approximately 74% of U.S. adults aged 20 and older were classified as overweight or obese, with 42.1% ...

As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights ...

The nation's plastic surgeons report their practices are busier than ever as patients want to plump facial features affected by weight loss.

The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people ... but the improvements in brain volume and cognitive function were statistically significant.

Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...

Dozens of Aussie weight loss drug injection patients have complained of symptoms consistent with drug-induced hepatitis, ...

Primary care providers can use a new clinical advisory guideline to nutritionally support patients who are using GLP-1 ...

BARCELONA — GLP-1 medications took center stage at Vitafoods Europe, held May 20 to 22 in Barcelona. Discussions at the show ...

Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...